Back To: Home : Featured Technology : Stem Cell

CLICK HERE FOR WHAT'S NEW IN:
 

StemCells secures patent portfolio
December 2013
EDIT CONNECT

SHARING OPTIONS:

NEWARK, Calif.—StemCells Inc. has acquired a portfolio of issued U.S. and Canadian patents for which it previously had an exclusive worldwide license. The patents cover the manufacture and proliferation of purified populations of human neural stem cells as well as their use as therapeutics and in drug discovery. With this acquisition, StemCells is relieved of all milestone and royalty responsibilities under the license agreements for products claimed by the patents. In consideration for the portfolio, StemCells will issue 139,548 shares of common stock to Neurospheres Holdings Ltd. Martin McGlynn, StemCells’ president and CEO, noted that “The potential value of these patents continues to grow in light of the encouraging data emerging from the clinical trials of our HuCNS-SC cells, and acquiring them outright on these terms was in the best interests of our stockholders.”
 
Code:

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.